Files application to list shares on American Stock Exchange
HARBIN, China, March 3 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (OTC Bulletin Board: CSKI; "China Sky" or "the Company"), a manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic products in China, announced today the appointment of four new independent directors to its board -- including Song Chun Fang, Jiang Qi Feng, Zhao Jie and Qian Xu Feng. As a result, the number of directors has increased from three to seven. The changes were made in conjunction with the Company filing an application to list its shares on the American Stock Exchange.
Song Chun Fang, 68, has held various positions including Director of Surgery Research Room and Director of Graduate Students of the Surgery Department at the First Clinical College of Harbin Medical University in Heilongjiang, China since 1964. Additionally, he has served as the Acting Director of the Heilongjiang Professional Surgery Committee, Commissary of the Degree Commission of China, Director of Key Laboratory of Cell Transplantation of the Ministry of Public Health of China, Vice-Chairman of Heilongjiang Medicine Association, Vice-Chairman of Heilongjiang Physician Association, and Director of Heilongjiang (Special) Medical Treatment Application Administration Committee since 1998. He obtained his Bachelor's degree in Medical Treatment from Harbin Medical University.
Jiang Qi Feng, 25, has served as Teaching Assistant and Research Assistant at Simon Fraser University since 2006. He obtained his Bachelor's degree in Bio-Statistics and Mathematics from University of British Columbia, Canada, and his Masters degree in Computer Science from Simon Fraser University, Canada.
Zhao Jie, 45, has served as a Tissue Specialist at the Replant
Department at Capital Health Transplant Services in Alberta, Canada since
1999. He obtained his Bachelor's Degree in Medicine from Harbin Medical
|SOURCE China Sky One Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved